India may soon introduce new law covering medical devices to spur manufacturing

India may take a long-expected step in parliament near the end of the year to create a separate law on medical devices that fits in with the manufacturing aims of the government led by Prime Minister Narendra Modi.

The Business Standard newspaper reports that the prime minister's office brought up the plans in a meeting with industry and said that a Medical Device Act would likely come in the winter legislative session that typically starts in late November and ends before the New Year.

Currently, India has several laws responsible for devices, including under the Drug and Cosmetics Act of 1940, which is also the subject of efforts for an overhaul on the pharmaceutical side.


Simplify and Accelerate Drug R&D With the MarkLogic Data Hub Service for Pharma R&D

Researchers are often unable to access the information they need. And, even when data does get consolidated, researchers find it difficult to sift through it all and make sense of it in order to confidently draw the right conclusions and share the right results. Discover how to quickly and easily find, synthesize, and share information—accelerating and improving R&D.

In both cases, legislative changes sought by industry and the government to reform the way the biomedical industries work and are regulated in the country have been hard to fashion as plans for more outside investment run into domestic industry opposition.

But Modi has said that both pharmaceutical and medical device manufacturing are key for his "Make in India" campaign to spur job growth and has pushed domestic players to get on board and compete in the market at home and abroad.

Last week, the Business Standard said Modi’s office spoke with the Federation of Indian Chambers of Commerce, or FICCI, the Association of Indian Medical Device Manufacturers, the Confederation of Indian Industry and the Medical Technology Association of India to get feedback on policies that will aid growth in the sector, the newspaper said.

“An added focus on promoting exports will add value," Probir Das, chairman of the FICCI Medical Device Forum told the newspaper.

Earlier this year, multinational device lobby group AdvaMed--or the Advanced Medical Technology Association--which represents nearly 300 members across Europe, India, China, Brazil, and Japan, urged Indian lawmakers to work faster to clear import roadblocks.

- here's the story from Business Standard

Related Articles:
AdvaMed spurs Indian lawmakers for new import rules on medical devices

Suggested Articles

With a brand new approval for Adakveo under its belt, Novartis Sunday flaunted an analysis showing the drug could cut patient hospitalizations by 40%.

BeiGene only just won its first Brukinsa nod in MCL. But it’s already pushing to join the CLL field, and Sunday it rolled out more data.

How long can one infusion of CAR-T drug Yescarta continue helping patients with refractory large B-cell lymphoma? Pretty long, Gilead showed Saturday.